Company profile: PanMed
1.1 - Company Overview
Company description
- Provider of interventional radiology and spine devices, specializing in kyphoplasty systems and tools (CurvePlus curved-needle procedure; InterV Balloon Kyphoplasty Kit with Osteoflex bone cement; InterVFlex; InterVMicro) and high-pressure PTA/angioplasty catheters (InterVMini, Boa). Focused on innovation, quality and service, with worldwide manufacture, sale and distribution.
Products and services
- InterV Balloon Kyphoplasty Kit: Modular kyphoplasty kit available in direct and traditional access options, featuring Osteoflex bone cement and ergonomic tools
- InterVFlex: Industrial-grade pre-curved kyphoplasty catheter with a balloon that withstands up to 50 ATM, engineered for minimal trauma and quick procedures
- CurvePlus: Custom-engineered kyphoplasty procedure employing a curved needle for cement delivery, featuring a 13G balloon passed through a 10G needle
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PanMed
MoonLake Immunotherapeutics
HQ: Switzerland
Website
- Description: Provider of clinical-stage biopharmaceutical solutions for inflammatory diseases, developing Sonelokimab—an investigational Nanobody® targeting IL-17A and IL-17F for psoriasis, hidradenitis suppurativa, and psoriatic arthritis—and conducting global clinical trials focused on unmet medical needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MoonLake Immunotherapeutics company profile →
TriMed
HQ: United States
Website
- Description: Provider of orthopedic implants and systems for the treatment of complex fractures and musculoskeletal injuries of the upper and lower extremities. Specializes in implants for distal radius fractures via open reduction internal fixation and offers systems and techniques to address pathologies of the wrist, ulna, clavicle, elbow, forearm, fifth metatarsal, and ankle.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriMed company profile →
NovaLign
HQ: United States
Website
- Description: Provider of orthopaedic medical devices based in Memphis, Tenn., offering an FDA 510(k)-cleared Intramedullary Fixation System—implants and instruments for treating long bone fractures, including the humerus and tibia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NovaLign company profile →
XpandOrtho
HQ: United States
Website
- Description: Provider of orthopedic devices and soft tissue balancing instruments for total knee replacement surgery, delivering real-time visual feedback to surgeons during procedures to improve the standard of care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XpandOrtho company profile →
Spinal Modulation
HQ: United States
Website
- Description: Provider of medical device research and development services and developer of spinal cord neurostimulator systems for the treatment of chronic intractable pain; based in Menlo Park, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spinal Modulation company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PanMed
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PanMed
2.2 - Growth funds investing in similar companies to PanMed
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PanMed
4.2 - Public trading comparable groups for PanMed
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →